Pyruvate dehydrogenase kinase 4 (PDK4) mRNA was identified as a transcript that was rapidly and generally induced by fibrates in various tissues of the mouse. The time course of induction was much faster than those of typical peroxisome proliferator-activated receptor a a (PPARa a)-regulated peroxisomal mRNAs. Rapid and efficient induction of PDK4 mRNA in various tissues would inactivate pyruvate dehydrogenase and stimulate fatty acid oxidation at the whole body level, leading to enhanced utilization of serum fatty acids and triglycerides. This metabolic switching mechanism can explain the early phase of the fibrate-induced decrease in the serum levels of triglycerides. Furthermore, the muscle in the fibrate-induced early state with limited activity of pyruvate dehydrogenase and low levels of fatty acids will utilize proteins as an energy source and extensive degradation of proteins may lead to myopathy or rhabdomyolysis.
Fibrates have been used in clinical practice to reduce triglyceride levels. Their hypolipidemic effects can be explained by their specific binding to and activation of the peroxisome proliferator-activated receptor a (PPARa). 1) In the liver, transcription of the genes for many fatty acid oxidationrelated enzymes and fatty acid transport proteins is almost coordinately up-regulated by fibrates in a PPARa-dependent manner. 2) In the muscle, fibrates induces the muscle-type carnitine palmitoyltransferase-I, 3) mitochondrial fatty acid uptake and oxidation. 4) Fibrates also stimulate the metabolism of triglyceride-rich lipoproteins by inducing lipoprotein lipase and repressing its inhibitory factor, apolipoprotein CIII. 5) All of these concerted fibrate-induced changes are thought to be key steps to decrease the serum levels of triglycerides. However, the time courses of all the these changes in the levels of mRNAs related to triglyceride metabolism are significantly slow as compared with that of the decrease in concentration of serum triglycerides, and the first step in the fibrate action has not been identified.
Most studies using Northern blotting analyses of the PPAR ligand-induced changes in the levels of mRNAs performed to date have been limited in that the time courses of changes were monitored with a resolution of days but not hours. 6, 7) The delayed metabolic changes can be complicated by various secondary effects and their mechanisms are difficult to elucidate. 8) Stimulation of fatty acid oxidation leading to a hypolipidemic effect may not result primarily or solely from the increases in the amounts of the enzymes involved in lipid metabolism. Lipid metabolism can be markedly affected by glucose metabolism, and "metabolic switching" by controlling the activities of key enzymes should exert a dominant effect.
This study was performed to examine the early effects of fibrates on the expression of mRNAs for the protein kinases for key enzymes in glucose and fatty acid metabolism. For this purpose, the cDNAs for PDK4, branched chain ketoacid dehydrogenase kinase (BCKDK) and AMP-activated protein kinase (AMPK) were obtained by cloning of PCR products of cDNA synthesized from poly(A) RNA isolated from the mouse liver using respective specific pairs of synthetic oligonucleotides designed according to the published sequences. [9] [10] [11] To examine the possibility that expression of the mRNAs for the key enzymes in glucose metabolism is affected shortly after fibrate administration, the time courses of the effects of Wy14,643 on the levels of PDK4, BCKDK, and AMPK mRNAs, together with apoCIII and typical PPARaregulated mRNAs, in the livers of mice were measured (Figs. 1A, B). PDK4 mRNA responded to the drug most rapidly among all the mRNAs examined. Administration of Wy14,643 resulted in a large induction of the mRNA reaching the maximum level within 1.5 h. In contrast, typical PPARa-regulated mRNAs started to respond after a time lag of a few hours. 6, 7) It is noteworthy that the fibrate-induced For the short time course study (h), Wy14,643 was injected interperitoneally, and for the long time course study (d), NZB mice were fed a diet containing Wy14,643. Total RNA (5 mg) isolated from individual livers was subjected to Northern blotting analysis using cDNAs for PDK4, BCKCK, peroxisomal bifunctional enzyme (HD), cytosolic liver type fatty acid binding protein (L-FABP), cytosolic thioesterase (CTE), apoCIII and apolipoprotein E (apoE; control for RNA loading) as probes. (A) Autoradiograms, and (B) relative changes in the mRNA levels determined using a BAS2000 image analyzer are shown.
down-regulation of apoCIII mRNA was quite slow. The level of apoCIII mRNA started to decrease after 1 d when the serum level of triglycerides had already dropped to almost 50% of the control level (not shown). These results indicated that down-regulation of apoCIII expression is not involved in the early action of Wy14,643 to reduce the serum levels of triglycerides. Instead, induction of PDK4 mRNA was most rapid and switching of the energy source from three-carbon compounds to fatty acids should have been induced in the liver. After induction, the level of the mRNA was not maintained for as long times as other PPARa-regulated mRNAs even though the mice were fed a diet containing Wy14,643. The short time course study also showed that a single dose of Wy14,643 was not sufficient to maintain the induced level of the mRNA. Thus, the induction of PDK mRNA by Wy14,643 was rapid but transient.
To examine whether PDK4 mRNA is also rapidly induced by Wy14,643 in the extra-hepatic tissues, the time courses of the effects of the drug in the intestine, skeletal muscle, and adipose tissues were measured by Northern blotting (Fig. 2) . The levels of typical PPARa-regulated mRNAs such as peroxisomal hydratase-dehadrogenase (HD) and liver type fatty acid-binding protein (L-FABP) in the liver reached a plateau within 1 d of feeding a diet containing Wy14,643 but increased gradually in the intestine as reported previously. 6) The levels of other tissue-type FABP mRNAs also increased gradually in the respective tissues. 12) In contrast, the levels of PDK4 mRNA in all the extra-hepatic tissues increased rapidly with a time course similar to that in the liver. This general induction was not observed for other PPARa-regulated mRNAs. Similar results were obtained with bezafibrate, clofibrate and ciprofibrate, but not with other peroxisome proliferator, phtalate and adipate (DEHP and DEHA). Among the tissues examined, the marked induction of the PDK4 mRNA in the muscle was striking.
DISCUSSION
PDK phosphorylates and inactivates pyruvate dehydrogenase complex which catalyzes irreversible decarboxylation of pyruvate to acetyl-CoA. Inactivation of the complex limits oxidation of glucose and three-carbon compounds to maintain blood glucose levels and promotes fatty acid oxidation. This is an adaptive mechanism for conditions of starvation, and PDK4 has been reported to be the most highly inducible among the four isoforms. 13, 14) This study showed that fibrates including Wy14,643, bezafibrate, clofibrate and ciprofibrate specifically and rapidly induce PDK4 mRNA in the liver, intestine, skeletal muscle and fat of mice. Sugden et al. reported that the renal PDK4 protein level was also markedly increased in wild-type mice but was induced only marginally in PPARa-null mice by starvation. 13) Thus, it is likely that fibrates generally induce PDK4 at the body level. This response is more rapid and more general than induction of the fatty acid utilization enzymes that are mostly limited to the liver. The induction of PDK4 has a marked effect on energy metabolism. Thus, the induction of PDK4 mRNA is not grouped together with the previously described induction of several mRNAs related to lipid metabolism but it is a discrete first step in the action of fibrates.
Based on the results of this study, a model for the early step of the hypolipidemic effect of fibrate is shown in Fig. 3 . Fibrates rapidly induce transcriptional activation of the PDK4 gene in various tissues, and this is the first step in the action of these agents. Inactivation of pyruvate dehydrogenase by the induced PDK is followed by metabolic switching 1510 Vol. 25, No. 11 This model presents induction of PDK as the first step in the hypolipidemic effect of fibrates. Inactivation of pyruvate dehydrogenase complex (PDC) by the induced PDK is followed by metabolic switching to limit oxidative fuel to fatty acids. Enhanced fatty acid utilization is accelerated by induction of enzymes involved in fatty acid utilization and repression of apoCIII. The metabolic switching and fibrate-induced decreased availability of triglycerides (TG) and fatty acids will force the muscle to use proteins as an energy source, and abnormal protein degradation leads to myopathy or rhabdomyolysis.
to limit oxidative fuel to fatty acids as in the adaptive process to conditions of starvation. Enhanced fatty acid utilization is further accelerated by induction of enzymes involved in fatty acid utilization and repression of apoCIII as demonstrated previously.
1) The metabolic switching and fibrate-induced decreased availability of triglycerides and fatty acids will force the muscle to use amino acids from proteins as an energy source and abnormal protein degradation would lead to myopathy or rhabdomyolysis. 15, 16) This model can explain two major questions regarding the action of fibrates; the rapid decrease of serum triglyceride level and the cause of rhabdomyolysis. These may be two sides of the same coin because metabolic switching is required for rapid and efficient utilization of fatty acids to decrease the serum triglyceride levels, leading the cells in a starved state to utilize proteins as an energy source. The model predicts that there is a correlation between the extent and prolongation of PDK4 induction and the potency of fibrates to cause rhabdomyolysis. To avoid fibrate-induced rhabdomyolysis, it will be important to control the induction of PDK4 in the muscle.
